Literature DB >> 18954935

Human embryonic stem cell-derived hematoendothelial progenitors engraft chicken embryos.

Tea Soon Park1, Elias T Zambidis, Jennifer L Lucitti, Alison Logar, Bradley B Keller, Bruno Péault.   

Abstract

OBJECTIVE: To investigate whether human embryonic stem cells (hESC) committed in culture into hematopoietic/endothelial cell progenitors can be further developed into mature blood and vascular cells following transplantation into chicken embryos.
MATERIALS AND METHODS: The yolk sac of 42- to 44-hour chicken embryos received yolk sac injections of unfractionated human embryoid body (hEB) cells, CD34-positive hEB cells, or CD34+CD45+ granulocyte colony-stimulating factor-mobilized human peripheral blood hematopoietic stem-progenitor cells. Human cells in the host were detected by flow cytometry and immunohistochemistry.
RESULTS: All injected cell populations engrafted chicken hematopoietic organs, as assessed by detection of CD45+ cells in the spleen, bursa of Fabricius, and thymus. CD34+ day -10 hEB cells showed the highest efficiency for producing human CD45+ cells in the hosts and yielded human glycophorin A+ erythroid, CD13+ myeloid, and CD19+ lymphoid cells in the spleen and bursa of Fabricius. Spleen cells from chimeric embryos also contained human colony-forming units-granulocyte macrophage, as assessed in methylcellulose colony-forming assays. Human endothelial cells expressing vascular endothelial-cadherin, von Willebrand factor, CD31, and the receptor for the Ulex europaeus lectin were also observed in the yolk sac vasculature following injection of either unfractionated or CD34+ day -10 hEB cells.
CONCLUSION: Primitive angiohematopoietic stem cells (total and CD34+ day -10 hEB cells) as well as adult hematopoietic stem cells could home to intraembryonic blood-forming organs following injection into the yolk sac. These observations demonstrate the utility of the avian embryo as a convenient and reliable host to model the angiohematopoietic development of human embryonic, or other early stem cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18954935     DOI: 10.1016/j.exphem.2008.08.007

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  11 in total

1.  Placental perivascular cells for human muscle regeneration.

Authors:  Tea Soon Park; Manuela Gavina; Chien-Wen Chen; Bin Sun; Pang-Ning Teng; Johnny Huard; Bridget M Deasy; Ludovic Zimmerlin; Bruno Péault
Journal:  Stem Cells Dev       Date:  2010-11-30       Impact factor: 3.272

Review 2.  Transplantation of mammalian embryonic stem cells and their derivatives to avian embryos.

Authors:  Ronald S Goldstein
Journal:  Stem Cell Rev Rep       Date:  2010-09       Impact factor: 5.739

Review 3.  Experimental approaches to derive CD34+ progenitors from human and nonhuman primate embryonic stem cells.

Authors:  Qiang Shi; John L VandeBerg
Journal:  Am J Stem Cells       Date:  2015-03-15

Review 4.  Capturing Human Naïve Pluripotency in the Embryo and in the Dish.

Authors:  Ludovic Zimmerlin; Tea Soon Park; Elias T Zambidis
Journal:  Stem Cells Dev       Date:  2017-06-26       Impact factor: 3.272

Review 5.  Multifunctional properties of chicken embryonic prenatal mesenchymal stem cells- pluripotency, plasticity, and tumor suppression.

Authors:  G Bhuvanalakshmi; Frank Arfuso; Arun Dharmarajan; Sudha Warrier
Journal:  Stem Cell Rev Rep       Date:  2014-12       Impact factor: 5.739

6.  Dysregulated gene expression during hematopoietic differentiation from human embryonic stem cells.

Authors:  Gautam Dravid; Yuhua Zhu; Jessica Scholes; Denis Evseenko; Gay M Crooks
Journal:  Mol Ther       Date:  2010-12-21       Impact factor: 11.454

Review 7.  Challenges and strategies for generating therapeutic patient-specific hemangioblasts and hematopoietic stem cells from human pluripotent stem cells.

Authors:  Ann Peters; Paul W Burridge; Marina V Pryzhkova; Michal A Levine; Tea-Soon Park; Christopher Roxbury; Xuan Yuan; Bruno Péault; Elias T Zambidis
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

Review 8.  Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells.

Authors:  Dan S Kaufman
Journal:  Blood       Date:  2009-08-03       Impact factor: 22.113

9.  Vascular progenitors from cord blood-derived induced pluripotent stem cells possess augmented capacity for regenerating ischemic retinal vasculature.

Authors:  Tea Soon Park; Imran Bhutto; Ludovic Zimmerlin; Jeffrey S Huo; Pratik Nagaria; Diana Miller; Abdul Jalil Rufaihah; Connie Talbot; Jack Aguilar; Rhonda Grebe; Carol Merges; Renee Reijo-Pera; Ricardo A Feldman; Feyruz Rassool; John Cooke; Gerard Lutty; Elias T Zambidis
Journal:  Circulation       Date:  2013-10-25       Impact factor: 29.690

Review 10.  Running the full human developmental clock in interspecies chimeras using alternative human stem cells with expanded embryonic potential.

Authors:  Justin Thomas; Ludovic Zimmerlin; Jeffrey S Huo; Michael Considine; Leslie Cope; Elias T Zambidis
Journal:  NPJ Regen Med       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.